Atlas Trials

Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma

Clinical trial NCT01011920 · COMPLETED

Trial details

NCT number
NCT01011920
Sponsor
International Extranodal Lymphoma Study Group (IELSG)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Central Nervous System Lymphoma
Start date
2009-11-01
Primary completion
2015-03-01
Enrollment
227

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.